Skip to content
Home/Companies/Biotech/Corimmun

Corimmun

Biotech·Germany·Exited 2012·Held 6yr
Entry
2006
Hold
6yr
Exit
2012

Who owns Corimmun?

Corimmun was owned by High-Tech Gruenderfonds (HTGF) through HTGF I (2005 vintage) from 2006 to 2012, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-11

High-Tech Gruenderfonds (HTGF)
Investor
High-Tech Gruenderfonds (HTGF)
HTGF I · 2005 · VC

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2012

More from HTGF I

Other portfolio companies in the same fund.

6 Wunderkinder (Wunderlist)
Exited 2015
SoftwareGermany· 2010
to
6Wunderkinder
Exited 2015
SoftwareGermany· 2010
to
Altruja
Exited 2021
SaaSGermany· 2010
to
ChromoTek
Exited 2020
BiotechGermany· 2010
to
ConWeaver
Active
Data & AnalyticsGermany· 2010
Dracoon
Exited 2021
CybersecurityGermany· 2010
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Corimmun

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Corimmun.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue